In today's health headlines we talk about how a group of doctors in Michigan have come up with a way to sterilize personal protective equipment so that they can be used more than once. Also, the FDA is..
Credit: FOX 47 News Michigan Duration: 02:12Published
Small amounts of a cancer-causing chemical have been found in the popular heartburn medication Zantac, as well is in generic forms of the drug, known as Ranitidine. The FDA is not issuing a recall and.. CBS News - Published
The maker of a generic version of Zantac is halting distribution. It comes after an FDA warning about a possible cancer-causing chemical found in Zantac and related heartburn medications. Dr. Jon.. CBS News - Published
The FDA recently warned about a potentially dangerous impurity in the popular heartburn drug Zantac. The nation's three largest pharmacy chains reacted by pulling it from store shelves. Dr. Jon LaPook.. CBS News - Published
There are increasing concerns about the popular heartburn drug Zantac and its generic version because of a chemical that could lead to cancer. Three large pharmacy chains in the U.S. recently pulled.. CBS News - Published
The popular heartburn drug ranitidine, the generic form of Zantac, was linked to cancer in September, prompting some voluntary recalls of the drug and an investigation by the FDA. A lab in California.. CBS News - Published Also reported by •CBS 2
The U.S. Food and Drug Administration has urged to withdraw Sanofi's heartburn drug Ranitidine as well as its generics from the market with immediate effect for possible contamination. The recall.. RTTNews - Published Also reported by •Motley Fool
The U.S. Food and Drug Administration is asking manufacturers and pharmacies to cease production and sale of over-the-counter Zantac, a medication that treats heartburn, due to potentially dangerous.. CTV News - Published
Major pharmacies had already pulled the popular heartburn drug and its generic equivalents due to a contaminant. Now the Food and Drug Administration says definitively they should not be sold or used. NPR - Published
Watch VideoThe FDA is asking manufacturers to remove all Zantac products and generic versions from store shelves "immediately." That includes prescription and over-the-counter versions.
Ranitidine.. Newsy - Published
The Food and Drug Administration on Wednesday asked companies to stop selling all forms of the heartburn drug Zantac, after concluding that a potential cancer-causing contaminant can build up in the.. Seattle Times - Published Also reported by •NYTimes.com
WASHINGTON (AP) — U.S. health regulators are telling drugmakers to immediately pull their popular heartburn drugs off the market after determining that a contamination issue with the medications.. SeattlePI.com - Published
Ranitidine will not be available for use in the U.S. after FDA pulls all remaining prescription and over-the-counter products containing the ingredient found in the heartburn medication Zantac. CBC.ca - Published Also reported by •Reuters •Reuters India
A laboratory in California has identified a possible clue to the link between the popular heartburn medication ranitidine, which is the generic form of Zantac, and cancer, which the Food and Drug.. Newsmax - Published Also reported by •CBS 2
CHICAGO--(BUSINESS WIRE)--Two consumers filed a class-action lawsuit claiming pharmaceutical giants GlaxoSmithKline (GSK) and Sanofi (SNY), among others, failed to warn consumers that the heartburn.. Business Wire - Published
Zantac and its generics are routinely used by millions of heartburn sufferers and available with or without a prescription. How did the drug become a cancer risk? Early studies show potential signs.
USATODAY.com - Published
Walgreens Boots Alliance Inc (NASDAQ:WBA) shares were higher in pre-market trading after Reuters reported the group is considering going private. The company, which has a market value of over US$55bn,.. Proactive Investors - Published